1np0: Difference between revisions
From Proteopedia
Jump to navigationJump to search
New page: left|200px<br /> <applet load="1np0" size="450" color="white" frame="true" align="right" spinBox="true" caption="1np0, resolution 2.50Å" /> '''Human lysosomal bet... |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:1np0.gif|left|200px]]<br /> | [[Image:1np0.gif|left|200px]]<br /><applet load="1np0" size="350" color="white" frame="true" align="right" spinBox="true" | ||
<applet load="1np0" size=" | |||
caption="1np0, resolution 2.50Å" /> | caption="1np0, resolution 2.50Å" /> | ||
'''Human lysosomal beta-hexosaminidase isoform B in complex with intermediate analogue NAG-thiazoline'''<br /> | '''Human lysosomal beta-hexosaminidase isoform B in complex with intermediate analogue NAG-thiazoline'''<br /> | ||
==Overview== | ==Overview== | ||
In humans, two major beta-hexosaminidase isoenzymes exist: Hex A and Hex | In humans, two major beta-hexosaminidase isoenzymes exist: Hex A and Hex B. Hex A is a heterodimer of subunits alpha and beta (60% identity), whereas Hex B is a homodimer of beta-subunits. Interest in human beta-hexosaminidase stems from its association with Tay-Sachs and Sandhoff disease; these are prototypical lysosomal storage disorders resulting from the abnormal accumulation of G(M2)-ganglioside (G(M2)). Hex A degrades G(M2) by removing a terminal N-acetyl-D-galactosamine (beta-GalNAc) residue, and this activity requires the G(M2)-activator, a protein which solubilizes the ganglioside for presentation to Hex A. We present here the crystal structure of human Hex B, alone (2.4A) and in complex with the mechanistic inhibitors GalNAc-isofagomine (2.2A) or NAG-thiazoline (2.5A). From these, and the known X-ray structure of the G(M2)-activator, we have modeled Hex A in complex with the activator and ganglioside. Together, our crystallographic and modeling data demonstrate how alpha and beta-subunits dimerize to form either Hex A or Hex B, how these isoenzymes hydrolyze diverse substrates, and how many documented point mutations cause Sandhoff disease (beta-subunit mutations) and Tay-Sachs disease (alpha-subunit mutations). | ||
==Disease== | ==Disease== | ||
| Line 11: | Line 10: | ||
==About this Structure== | ==About this Structure== | ||
1NP0 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with SO4, NGT and GOL as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Beta-N-acetylhexosaminidase Beta-N-acetylhexosaminidase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.2.1.52 3.2.1.52] Full crystallographic information is available from [http:// | 1NP0 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=SO4:'>SO4</scene>, <scene name='pdbligand=NGT:'>NGT</scene> and <scene name='pdbligand=GOL:'>GOL</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Beta-N-acetylhexosaminidase Beta-N-acetylhexosaminidase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.2.1.52 3.2.1.52] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1NP0 OCA]. | ||
==Reference== | ==Reference== | ||
| Line 18: | Line 17: | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Single protein]] | [[Category: Single protein]] | ||
[[Category: Cherney, M | [[Category: Cherney, M M.]] | ||
[[Category: James, M | [[Category: James, M N.G.]] | ||
[[Category: Knapp, S.]] | [[Category: Knapp, S.]] | ||
[[Category: Mahuran, D | [[Category: Mahuran, D J.]] | ||
[[Category: Mark, B | [[Category: Mark, B L.]] | ||
[[Category: Zhao, D.]] | [[Category: Zhao, D.]] | ||
[[Category: GOL]] | [[Category: GOL]] | ||
| Line 31: | Line 30: | ||
[[Category: homodimer]] | [[Category: homodimer]] | ||
''Page seeded by [http:// | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 14:08:27 2008'' | ||